This week, the Kohn lab is coming to New Orleans for #ASGCT2025 ! Another special year for us because our PI is this year’s @ASGCTherapy Founders Award recipient. Don’t miss the Founder’s Keynote tomorrow afternoon! Look out for the 👨🏻#genetherapy #PIDD #raredisease
1
4
14
Annual ASGCT Kohn lab (past and present) dinner. It's always great catching up with previous members. Hearing their success stories and how they're leading their own group inspires to us even more to be great in this field. #ASGCT2024
0
0
14
5th yr PhD candidate, Eva Segura, presenting our progress on lentivirus-based gene therapy for Alpha-Thalassemia. ##ASGCT2024
1
0
12
@C_Luthers31 presents his work where he is investigating our site-specific gene integration strategy on X-linked agammaglobulinemia (XLA) using a murine XLA-disease model. #ASGCT2024
0
2
4
Every year @ASGCTherapy reminds us how blessed we are to be under Dr. Donald B. Kohn’s mentorship. 🩸🧬🦠 ✂️ #ASGCT2024
1
2
29
Baltimore here we come! We're excted to see everyone again & learn more science at #ASGCT2024. We invite you to stop by on Thursday where Christopher Luthers (4th PhD candidate) will share our progress on developing a gene editing strategy for X-linked agammaglobulinemia (XLA).🧬
0
1
12
An early celebration for our lab before the holidays as our senior graduate student defends his PhD thesis. Congrats to our soon to be Dr. @PaulAyoubG 🥂 #genetherapy
4
2
22
Let’s Talk Science. Learn more about UCLA’s progress in bridging the gap between basic and translational research. This seminar will focus on the journey from moving research from bench and bedside. Today @ 5:30-630 pm PST. ucla.zoom.us/webinar/regist…
0
0
4
3rd year Phd Candidate Christopher Luthers is here to discuss our gene editing strategy to develop a long-term cure for X-linked Agammaglobulinemia (XLA), an immune disorder that causes the inability to produce mature B cells which results in low levels of antibody production.
0
0
9
Today at @UCLATDG ‘s annual LA Bioscience Summit (#LABEST2023), A panel of academic researchers focused on regenerative medicine (including our own Dr. Donald B Kohn) are discussing their experiences in moving their research from bench to benchside.
0
1
17
PhD candidate, Eva Segura, presenting her project during the lightning round at the 2nd Annual Ginsburg Symposium: Frontiers in Pediatric Precision Health. #UCLA #GeneTherapy
0
0
11
Catch Poster #1194 on the 3rd day of #ASGCT2023. PhD candidate @PaulAyoubG will be presenting the development of our Lentiviral Vectors with Regulated Expression to Treat X-Linked Lymphoproliferative Disease” #GeneTherapy #XLP #RareDisease
0
3
17
Catch Poster #630 on the second day of #ASGCT2023. 4th yr PhD candidate Eva Segura Gensler is here to present our work on “Alpha Globin Lentiviral Vectors for Hematopoietic Stem Cell Gene Therapy of Alpha-Thalassemia” #GeneTherapy
0
0
13
Ending #ASGCT23 Day 1 with the Kohn lab dinner. ASGCT is the event for us where the past and present members celebrate together. 🙏🏻
0
0
13
A day before #ASGCT2023 , Dr. Claire Booth, Dr. Barry Byrne, Dr. Edward Smith & Dr. Stephano Rivella are visiting the most beautiful campus to share their research to the UCLA community. #GeneTherapy
0
0
9
POV: you are a gene therapy clinical trial that was abandoned by a company but now acquired again by the founding academic researchers to continue your mission to cure all ADA-SCID patients.
0
3
20
Ending this week with our annual Kohn/Crooks Lab retreat 👨🏻🔬👩🏻🔬 This retreat is another reminder of how collaborations speed up the scientific progress. Current and new members are about to learn how many collaborations these two labs are actually doing 🤝
0
0
15
We are proud to share that our PhD candidate, Eva Segura Gensler, is having a blast in NY sharing our progress on Alpha-Thalassemia #GeneTherapy at the 11th Cooley’s Anemia Symposium. 🩸
0
6
19
Amazing story from Alysia Padillo-Vaccaro whose daughter was born with ADA-SCID but received gene therapy. Evangelina is now 10 and plays a lot of sports 🙌🏼 As trials continue, we’re excited to share more stories like Evangelina’s scidcompass.org/news/evangelin…
0
5
25
The last talk from our lab on the last day of @ASGCTherapy 🌞. LAD-I clinical trial in collaboration with @RocketPharma. #ASGCT2022
0
1
9
It’s time to celebrate THE Dr. Donald Kohn, MD for receiving one of the highest honors in the field cell and gene therapy. #ASGCT2022
0
1
14
One of the most important lessons one will never forget after working in the Kohn lab - Always have positive and negative controls.
0
1
22
Dr. Francis Collins brings up the importance of working towards in vivo gene therapy. #ASGCT2022
0
1
9
As Dr. Donald Kohn shares his work on ADA-SCID gene therapy, we want to remind that this clinical trial has resumed with the support of @CIRMnews . We ask for your continuous support as we treat more patients with #ADASCID. #ASGCT2022
0
3
19
The @ASGCTherapy 2022 Outstanding Achievement Award recipient. We are so proud of you! #ASGCT2022
0
8
39
Day 3 in DC. ☀️ This is the session we’ve been waiting for! Two influential scientists in the gene therapy field; Dr. Donald Kohn will receive the Outstanding Achievement Award and Dr. Francis Collins will receive the Founders Award. #ASGCT2022
0
0
1
Pre-celebration to our biggest day of the conference. Segway tour around DC before we witness THE Dr. Donald Kohn receive the @ASGCTherapy Outstanding Achievement Award (10 am EST) #ASGCT2022
0
3
14
And to end our second day of the conference, we present “Base Editing of Hematopoietic Stem Cells Rescues T-Cell Development for CD3d Severe Combined Immunodeficiency” 🧬 #ASGCT2022
1
5
19
Day 2 in DC! 🌞 You can learn more about our work on using base editing to rescue T-cell development for CD3d-SCID. (5 pm EST) #ASGCT2022
0
1
14
Our talented 2nd year PhD student presenting “Quantification of DNA Contamination within Recombinant Adeno Associated Virus Preps Correlates with CD34+ Cell Potential” at the poster session! #ASGCT2022
1
1
14
Happening right now! “Treating Sickle Cell Disease with Lentiviral Vectors Combining an Anti-Sickling βAS3-Globin Gene with BCL11A and ZNF410 MicroRNA Adapted Short Hairpin RNAs” #ASGCT2022
0
0
8
Good morning Washington, D.C.! ☀️ Excited to hear everyone’s progress in the gene therapy field. 🧬 #ASGCT2022
0
0
16
This year’s ASGCT will be extra special because we will not only to share our work to the community, but we will also witness our mentor receive the Outstanding Achievement Award for his continuous leadership and accomplishments in the gene therapy field.🍾 #ASGCT22
1
3
19
We are filled with gratitude to have an opportunity to celebrate together this year. Happy Holidays from the Kohn lab.🎄🎅
0
0
8
We want to congratulate our second scientist coming from the Kohn lab in 2021, Ryan Wong, for his successful dissertation defense.🍾 The lentivirus gene therapy field now gains two more talented scientists 🦠🧬
0
1
12
Congratulations to our PhD candidate, @nebulahan1 , for her successful dissertation defense. Best of luck on your new journey! 👩🏻🎓🍾
2
0
10
For the last day of #ASGCT21 , we invite you to listen to our graduate student's (@nebulahan1) talk on how to enhance titer for complex lentiviral vectors. It will be on Lentiviral Vector Manufacturing ( 1 pm ET). Thank you @ASGCTherapy for this opportunity.
0
2
10
Happening right now at #ASGCT21 ! "Autologous Ex Vivo Lentiviral Gene Therapy for the Treatment of ADA-SCID" presented by our collaborator in UCL, Dr. Claire Booth.
0
0
4
We would like to express our sorrow and condolences to the Broad family. Eli Broad has made a huge impact on the scientific and medical research. His legacy will continue to live on. Thank you, Eli.
0
1
11
